Heghine Khachatryan: Heavy Menstrual Bleeding is Not ‘Normal’ – It is Often Missed Pathology
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“Heavy menstrual bleeding is not ‘normal’ — it is often missed pathology.
For too long, heavy menstrual bleeding (HMB) has been normalized, underestimated, and frequently misdiagnosed.
Behind what is often dismissed as a ‘gynecological issue,’ there may be an underlying hemostatic disorder — including von Willebrand disease, platelet function defects, or other coagulation abnormalities.
The clinical reality is concerning:
Many women remain undiagnosed for years, presenting later with anemia, perioperative bleeding, or complications during pregnancy and childbirth.
Pregnancy introduces an additional layer of complexity.
Hemostasis is dynamically altered, and in women with unrecognized bleeding disorders, this may result in:
- increased risk of miscarriage
- postpartum hemorrhage
- preventable maternal morbidity
Misdiagnosis is not benign — it is systemic failure.
We must shift from symptom-based reassurance to structured hemostatic evaluation, especially in:
- adolescents with HMB
- women with iron deficiency
- patients with bleeding history prior to surgical or reproductive interventions
This is not only a clinical issue — it is a matter of health equity, awareness, and diagnostic capacity.
The time has come to integrate hemostasis into routine women’s health assessment — not as an exception, but as a standard.”

Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Mar 31, 2026, 12:58Akshat Jain: Invisible Blood – The Hidden Battle with Von Willebrand Disease
-
Mar 31, 2026, 12:50Emmanuele Kouvousis: DOAC Dose Adjustments for Older Patients
-
Mar 31, 2026, 12:34How Clinicians Prioritize Factors in Red Blood Cell Transfusions While Following Guidelines – AABB
-
Mar 31, 2026, 12:13Tareq Abadl: What if a Hospital Bacterium Can Survive on Dry Surfaces for Days to Weeks?
-
Mar 31, 2026, 11:35Lale Tokgözoğlu: Significant CV Benefit of Lowering LDL to 44 mg/dL in Diabetes
-
Mar 31, 2026, 09:08Shamee Shastry: Sharing Perspectives on Therapeutic Apheresis at AIIMS CME
-
Mar 30, 2026, 18:24Tayyab Ibrahim: How the ‘Milli-Spinner’ is Changing Blood Clot Treatment
-
Mar 30, 2026, 17:49Peter Antevy: The Blood Type in the Cooler Shouldn’t Decide Whether She Lives
-
Mar 30, 2026, 17:40Sajjad Ullah Mphil: The Impact of Pharmacist-Led Anticoagulation Care in VTE